Thiol redox barrier; local and systemic surveillance against stress and inflammatory diseases.
A 12-kDa protein with redox-active dithiol in the active site -Cys-Gly-Pro-Cys-, human thioredoxin 1 (TRX) has demonstrated an excellent anti-inflammatory effect in various animal models. TRX is induced by various oxidative stress factors, including ultraviolet rays, radiation, oxidation, viral infections, ischemia reperfusion and anticancer agents, and are involved in the pathogenesis and progression of various diseases. We have demonstrated that systemic administration and transgenic overexpression of TRX is effective in a wide variety of in vivo inflammatory disease models, such as viral pneumonia, acute lung injury, chronic obstructive pulmonary disease, indomethacin-induced gastric injury, and dermatitis. Our recent studies indicate that topically applied TRX prevents skin inflammation via the inhibition of local formation of inflammatory cytokines and chemokines. These indicate that the activation of inflammasome in skin and mucosa may be regulated by TRX. These suggest that application of TRX may be useful for the treatment of various skin and mucosal inflammatory disorders. Based on these results, we are conducting clinical studies to develop human recombinant thioredoxin 1 (rhTRX) pharmaceuticals. We have also developed substances that increase the expression of TRX in the body (TRX-inducing substances) in vegetables and other plant ingredients, and we are also developing skin-care products and functional foods that take advantage of the anti-inflammation and anti-allergic action of TRX.
Department of Biological Response, Institute for Virus Research, Kyoto University, Kyoto, Japan; Japan Biostress Research Promotion Alliance (JBPA), Japan. Electronic address: yodoi@skyblue.ocn.ne.jp.
Junji
J
Yodoi
Japan Biostress Research Promotion Alliance (JBPA), Japan.
Hai
H
Tian
Department of Biological Response, Institute for Virus Research, Kyoto University, Kyoto, Japan.
Hiroshi
H
Masutani
Department of Biological Response, Institute for Virus Research, Kyoto University, Kyoto, Japan.
Hajime
H
Nakamura
D000818:Animals; D006801:Humans; D007249:Inflammation / Q000517:prevention & control*; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D013879:Thioredoxins / Q000378:metabolism*
D013879:Thioredoxins
Anti-allergic action; Anti-inflammation; Development of drug; Inflammatory diseases; Redox regulation; Skin care and functional food; Stress; Thioredoxin